Polymorphism in environment responsive genes and association with Parkinson disease

Molecular and Cellular Biochemistry

Volumn 312, Issue 1-2, 2008, Pages 131-138

  Singh, Madhu ^a   Khan, Anwar J ^a   Shah, Parag P ^a   Shukla, Rakesh ^a,b   Khanna, V K ^a   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Detoxication; Dopamine; Genotype combinations; PD; Polymorphisms

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MANGANESE SUPEROXIDE DISMUTASE;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DETOXIFICATION; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARKINSON DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADAPTATION, BIOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DOPAMINE; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 42149180679     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9728-2     Document Type: Article

References (34)

1. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53:S26-36
2. Warner TT, Schapira AH (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53:S16-S25
3. Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P (2004) alpha-Synuclein and Parkinson's disease. FASEB J 18:617-626
4. Maimone D, Dminici R, Grimaldi LME (2001) Pharmacogenetics of neurodegenerative diseases. Eur J Pharmacol 413:11-29
5. BenMoyal-Segal L, Soreq H (2006) Gene-environment interactions in sporadic Parkinson's disease. J Neurochem 97:1740-1755
6. Wu RM, Cheng CW, Chen KH, Shan DE, Kuo JW, Ho YF et al (2002) Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson's disease in Taiwanese. J Neural Transm 109:1403-1414
7. Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T et al (2003) Glutathione-S-transferase M1, T1 and P1 polymorphisms and Parkinson's disease. Neurosci Lett 337:5-8
8. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y (1996) Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 226:561-565, Erratum in: Biochem Biophys Res Commun. 1996 Dec 4 229:361
9. Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS et al (1994) Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 36:387-396
10. Toda T, Momose Y, Murata M, Tamiya G, Yamamoto M, Hattori N, Inoko H (2003) Toward identification of susceptibility genes for sporadic Parkinson's disease. J Neurol 250(Suppl 3):III40-43
11. Schur BC, Bjerke J, Nuwayhid N, Wong SH (2001) Genotyping of cytochrome P450 2D6*3 and*4 mutations using conventional PCR. Clin Chim Acta 308:25-31
12. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P (2001) Elucidation of CYP2E1 5′ regulatory RsaI/PstI allelic variants and their role in risk for oral cancer. Oral oncol 37:437-445
13. Vidal F, Lorenzo A, Auguet T, Olona M, Broch M, Gutierrez C et al (2004) Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: Lack of association with alcoholism and alcoholic liver disease. J Hepatol 41:744-750
14. Harries LW, Stubberns MJ, Forman D, Howard GCW, Wolf CR (1997) Identification of genetic polymorphisms at the glutathione-S-transferase P1 locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644
15. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione s-transferase Theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276
16. Akyol O, Canatan H, Yilmaz HR, Yuce H, Ozyurt H, Sogut S, Gulec M, Elyas H (2004) PCR/RFLP based cost-effective identification of SOD2 signal (leader) sequence polymorphism (Ala-9Val) using NgoM IV: A detailed methodological approach. Clin Chim Acta 345:151-159
17. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG (1997) Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 74:154-156
18. Spitz MR, Shi H, Yang F, Hudman KS, Jiang H, Chamberlain RM et al (1998) Case-Control Study of the D2 Dopamine Receptor Gene and Smoking Status in Lung Cancer Patients. J Nat Cancer Inst 90:358-363
19. Lin CN, Liu HC, Tsai SJ, Liu TY, Hong CJ l (2002) Association study of Parkinson's disease and a dopamine transporter gene polymorphism (1215A/ G). Eur Neurol 48:207-209
20. Bialecka M, Klodowska-Duda G, Honczarenko K, Gawronska-Szklarz B, Opala G, Safrano K, Drozdzik M (2007) Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), n-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. Parkinsonism Relat Disord 13(4):224-229
21. Gołab-Janowska M, Honczarenko K, Gawrońska-Szklarz B, Potemkowski A (2007) CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia. Neurol Neurochir Pol 41(2):113-121
22. Elbaz A, Dufouil C, Alperovitch A (2007) Interaction between genes and environment in neurodegenerative diseases. C R Biol 330(4):318-328
23. Mellick GD (2006) CYP450, genetics and Parkinson's disease: Gene x environment interactions hold the key. J Neural Transm Suppl 70:1-7
24. Palma GD, Mozzoni P, Mutti A, Calzetti S, Negrotti A (1998) Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 352:1986-1987
25. Stroombergen M, Waring RH (1999) Determination of glutathionine S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 18:141-145
26. Rahbar A, Kempkes M, Muller Th, Reich S, Welter FL, Meves S, Przuntek H, Bolt HM, Kuhn W (2000) Glutathione S-tansferase polymorphism in Parkinson's disease. J Neurol Transm 107:331-334
27. Grasbon-Frodl EM, Kosel S, Riess O, Muller U, Mehraein P, Graeber MB (1999) Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem Biophys Res Commun 225:749-752
28. Farin FM, Hitosis Y, Hallagan SE, Kushleika J, Woods JS, Janssen PS, Smith-Weller T et al (2001) Genetic polymorphism of superoxide dismutase in Parkinson's disease. Mov Disord 16:705-707
29. Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L (2000) Platelet monoamine oxidase activity is related to MAO-B intron 13 genotype. J Neurol Transm 107:523-530
30. Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY et al (2003) Dopamine D2 receptor Taq 1A and Taq1B polymorphisms in Parkinson's disease. Mov Disord 18:593-595
31. Kimura M, Matsushita S, Arai H, Takeda A, Higuchi S (2001) No evidence of association between a dopamine transporter gene polymorphism (1215A/ G) and Parkinson's disease. Ann Neurol 49:276-277
32. Morino H, Kawarai T, Izumi Y, Kazuta T, Oda M, Komure O, Udaka F, Kameyama M, Nakamura S, Kawakami H (2000) A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease. Ann Neurol 47:528-531
33. Bon MAM, Jansen Steur ENH, de Vos RAI, Vermis I (1999) Neurogenetic correlates of Parkinson's disease: Apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci Lett 266:149-151
34. Dick F, Palma GD, Ahmadi A, Osborne A, Scott NW, Prescott GJ, et al (2007) Gene-environment interactions in parkinsonism and Parkinson's disease: The Geoparkinson study. Occup Environ Med 64(10):673-680